Immunological and clinical markers of PASC: Insights from mild and severe cases six months post-infection, 2025, William Mouton et al

Discussion in 'Long Covid research' started by Mij, Feb 21, 2025 at 10:14 PM.

  1. Mij

    Mij Senior Member (Voting Rights)

    Messages:
    9,999
    Abstract
    Post-acute sequelae of COVID-19 (PASC) is a complex and multifaceted clinical challenge requiring to emphasize its underlying pathophysiological mechanisms.

    This study assessed hundreds of virological, serological, immunological, and tissue damage biomarkers in two patient cohorts who experienced mild (n=270) or severe (n=188) COVID-19, 6 to 9 months post-initial infection, and in which 40% and 57.4% of patients, respectively, developed PASC. Blood analysis showed that mains differences observed in humoral, viral, and biological biomarkers were associated with the initial COVID-19 severity, rather than being specifically linked to PASC.

    However, patients with PASC displayed altered CD4+ and CD8+ memory T-cell subsets, with higher cytokine-secreting cells and increased terminally differentiated CD45RA+ effector memory T cells (TEMRA). Elevated SARS-CoV-2-specific T cells responsive to nucleocapsid/membrane proteins with a TEMRA phenotype were also observed.

    A random forest model identified these features and initial symptom duration as top variables discriminating PASC, achieving over 80% classification accuracy.
    LINK
     
  2. SNT Gatchaman

    SNT Gatchaman Senior Member (Voting Rights)

    Messages:
    6,312
    Location:
    Aotearoa New Zealand
    (Supplementary figures not currently downloadable)
     
    Peter Trewhitt and Deanne NZ like this.
  3. SNT Gatchaman

    SNT Gatchaman Senior Member (Voting Rights)

    Messages:
    6,312
    Location:
    Aotearoa New Zealand
     
  4. Utsikt

    Utsikt Senior Member (Voting Rights)

    Messages:
    780
    Location:
    Norway
    Completely anecdotal, but I have severe PASC (ME/CFS) and I don’t have EBV antibodies.
     
    Peter Trewhitt likes this.
  5. Midnattsol

    Midnattsol Moderator Staff Member

    Messages:
    3,894
    I didn't either when I first got sick. I did have CMV antibodies though.
     
    Peter Trewhitt likes this.
  6. Utsikt

    Utsikt Senior Member (Voting Rights)

    Messages:
    780
    Location:
    Norway
    I also have CMV IgG, but not IgM.
     
    Peter Trewhitt likes this.
  7. EndME

    EndME Senior Member (Voting Rights)

    Messages:
    1,387
    So IgG,IgM (EBNA, VCA etc) are all negative, or you've had a past infection but no indication of anything more recent (as in most people with ME/CFS)?
     
    Peter Trewhitt likes this.
  8. Midnattsol

    Midnattsol Moderator Staff Member

    Messages:
    3,894
    Mine was also IgG. Apparently there was an outbreak at the hospital when I was born, but I had seemingly not been one if the babies infected. My mother was very surprised I had antibodies and could think of no other place I could have been exposed than that hospital outbreak.
     
    Peter Trewhitt likes this.
  9. Utsikt

    Utsikt Senior Member (Voting Rights)

    Messages:
    780
    Location:
    Norway
    Yes. I got ME/CFS from PCR-confirmed Covid three years ago.
    • Negative EBV EBNA (IgG and IgM) and VCA (IgG)
    • Negative Paravirus B19 IgG and IgM
    • Positive CMV IgG, negative IgM
    • Positive Varicella-zoster virus IgG
     
    Peter Trewhitt likes this.
  10. Utsikt

    Utsikt Senior Member (Voting Rights)

    Messages:
    780
    Location:
    Norway
    I have no idea how I got it. Idk if my sisters had it. One had mono as a child, all three of us had Varielle Zoster (vannkopper/chicken pox) before school age.
     
    Peter Trewhitt likes this.

Share This Page